All Stories

  1. Oral Nicotine Product Use and E-Cigarette Use Persistence in Adolescents and Young Adults: An Analysis Using Augmented Inverse Probability Weighting
  2. COPD Stage Progression and Regression: a Multistate Transition Analysis of The COPDGene Cohort
  3. Joinpoint trend analysis of prevalence of combustible and non-combustible tobacco product use by adults in the United States, using cross-sectional data from NHIS 2015–2023
  4. Recent trends in sales of electronic nicotine devices and oral nicotine pouches by flavour
  5. SimSmoke simulation models by educational status: past and future US trends and the potential role of policy
  6. SimSmoke simulation models distinguished by race/ethnicity: past and future trends and the potential role of policy
  7. Canada smoking and vaping model (SAVM): the public health impact of NVP availability in Canada
  8. Modeling the impact of smoking on mortality in Argentina from 2000 to 2100. A Maximum Potential Reduction in Premature Mortality analysis
  9. An update of a systematic review and meta‐analyses exploring flavours in intervention studies of e‐cigarettes for smoking cessation
  10. Transformation of the tobacco product market in Japan, 2011–2023
  11. Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of adults in the PATH Study in 2017–2019 vs 2019–2021
  12. Impact of tobacco retail licensing on youth smoking in Virginia: A system dynamics simulation approach
  13. The Public Health Impact of a Ban on Flavored Cigars: A Decision-Theoretic Policy Framework
  14. Evaluating trends in cigarette and HTP use in Japan and measurement issues in the National Health and Nutrition Survey
  15. The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review
  16. The impact of removing a ban on electronic nicotine delivery systems using the Mexico smoking and vaping model (SAVM)
  17. Cross-state Border Nicotine Vaping Products Purchase – Early Evidence from State Emergency Sales Restrictions in 2019
  18. How do users compare the costs between nicotine vaping products and cigarettes? Findings from the 2016–2020 International Tobacco Control United States surveys
  19. Cigarette Prices and Disparities in Cessation in the United States
  20. The smoking and vaping model, A user-friendly model for examining the country-specific impact of nicotine VAPING product use: application to Germany
  21. Modeling the future of tobacco control: Using SimSmoke to explore the feasibility of the tobacco endgame in Korea
  22. Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model
  23. Potential Implications for Tobacco Industry Transformation of the Acquisition of Swedish Match by Philip Morris International
  24. The longitudinal association between coupon receipt and established cigarette smoking initiation among young adults in USA
  25. Are the Relevant Risk Factors Being Adequately Captured in Empirical Studies of Smoking Initiation? A Machine Learning Analysis Based on the Population Assessment of Tobacco and Health Study
  26. Birth Cohort‒Specific Smoking Patterns by Family Income in the U.S.
  27. Patterns of Birth Cohort‒Specific Smoking Histories by Race and Ethnicity in the U.S.
  28. Patterns of Birth Cohort‒Specific Smoking Histories in Brazil
  29. Summary and Concluding Remarks: Patterns of Birth Cohort‒Specific Smoking Histories
  30. Time-varying association between cigarette and ENDS use on incident hypertension among US adults: a prospective longitudinal study
  31. Using the Past to Understand the Future of U.S. and Global Smoking Disparities: A Birth Cohort Perspective
  32. Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015–2017 vs 2017–2019
  33. Cigarettes, ENDS Use, and Chronic Obstructive Pulmonary Disease Incidence: A Prospective Longitudinal Study
  34. Do Tobacco Companies Have an Incentive to Promote “Harm Reduction” Products?: The Role of Competition
  35. Chemical Profiles and Toxicity of Electronic Cigarettes: An Umbrella Review and Methodological Considerations
  36. An exploration of flavours in studies of e‐cigarettes for smoking cessation: secondary analyses of a systematic review with meta‐analyses
  37. The Longitudinal Association Between Cigarette Coupon Receipt and Short-term Smoking Cessation Among US Adults
  38. Do Current Smokers and Ex-Smokers Who Use Nicotine Vaping Products Daily Versus Weekly Differ on Their Reasons for Vaping? Findings from the 2020 ITC Four Country Smoking and Vaping Survey
  39. A Decision-Theoretic Public Health Framework for Heated Tobacco and Nicotine Vaping Products
  40. Associations Between E-cigarette Use and E-cigarette Flavors With Cigarette Smoking Quit Attempts and Quit Success: Evidence From a U.S. Large, Nationally Representative 2018–2019 Survey
  41. Impact of vaping restrictions in public places on smoking and vaping in the United States—evidence using a difference‐in‐differences approach
  42. The Australia Smoking and Vaping Model: The Potential Impact of Increasing Access to Nicotine Vaping Products
  43. Longitudinal Associations Between Exclusive and Dual Use of Electronic Nicotine Delivery Systems and Cigarettes and Self-Reported Incident Diagnosed Cardiovascular Disease Among Adults
  44. Health Effects of Electronic Cigarettes: An Umbrella Review and Methodological Considerations
  45. Public health impact of a US menthol cigarette ban on the non-Hispanic black population: a simulation study
  46. An analysis of cigarette sales during Poland’s menthol cigarette sales ban: small effects with large policy implications
  47. The Impact of Current Tobacco Product Use Definitions on Estimates of Transitions Between Cigarette and ENDS Use
  48. Impact of Canada’s menthol cigarette ban on quitting among menthol smokers: pooled analysis of pre–post evaluation from the ITC Project and the Ontario Menthol Ban Study and projections of impact in the USA
  49. Follow the money: a closer look at US tobacco industry marketing expenditures
  50. Trends in Exclusive, Dual and Polytobacco Use among U.S. Adults, 2014–2019: Results from Two Nationally Representative Surveys
  51. Poland is not replicating the HTP experience in Japan: a cautionary note
  52. Cigarette Pack Price and Its Within-Person Association With Smoking Initiation, Smoking Progression, and Disparities among Young Adults
  53. A longitudinal analysis of smoke‐free laws and smoking initiation disparities among young adults in the United States
  54. Public health impact of a US ban on menthol in cigarettes and cigars: a simulation study
  55. Tobacco retail availability and cigarette and e-cigarette use among youth and adults: a scoping review
  56. Sociodemographic Patterns of Exclusive and Dual Use of ENDS and Menthol/Non-Menthol Cigarettes among US Youth (Ages 15–17) Using Two Nationally Representative Surveys (2013–2017)
  57. Response to Braillon (2021): No, not the exception
  58. The Mexico SimSmoke tobacco control policy model: Development of a simulation model of daily and nondaily cigarette smoking
  59. An Expert Elicitation on the Effects of a Ban on Menthol Cigarettes and Cigars in the United States
  60. US Nicotine Vaping Product SimSmoke Simulation Model: The Effect of Vaping and Tobacco Control Policies on Smoking Prevalence and Smoking-Attributable Deaths
  61. Public health implications of vaping in the USA: the smoking and vaping simulation model
  62. Public Health Implications of Vaping in The US: The Smoking and Vaping Simulation Model
  63. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study
  64. An Analysis of the Altria-Juul Labs Deal: Antitrust and Population Health Implications
  65. E-cigarettes and Cessation: Asking Different Questions Requires Different Methods
  66. Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1–4): multistate transition modelling accounting for complex survey design
  67. The Kentucky SimSmoke Tobacco Control Policy Model of Smokeless Tobacco and Cigarette Use
  68. England SimSmoke: the impact of nicotine vaping on smoking prevalence and smoking‐attributable deaths in England
  69. Patterns of E-cigarette Use and Subsequent Cigarette Smoking Cessation Over 2 Years (2013/2014–2015/2016) in the Population Assessment of Tobacco and Health Study
  70. The actual and anticipated effects of a menthol cigarette ban: a scoping review
  71. The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes
  72. Support for Minimum Legal Sales Age Laws Set to Age 21 Across Australia, Canada, England, and United States: Findings From the 2018 ITC Four Country Smoking and Vaping Survey
  73. Public Health Implications of Vaping in the US: The Smoking and Vaping Simulation Model
  74. Taxation reduces smoking but may not reduce smoking disparities in youth
  75. Vaping popularity did not increase smoking rate
  76. Costs of vaping: evidence from ITC Four Country Smoking and Vaping Survey
  77. Smoking trends in Mexico, 2002–2016: before and after the ratification of the WHO’s Framework Convention on Tobacco Control
  78. Tobacco 21 Laws in Europe: A Policy Whose Time Has Come
  79. The Minnesota SimSmoke Tobacco Control Policy Model of Smokeless Tobacco and Cigarette Use
  80. Altria-Juul Labs deal: why did it occur and what does it mean for the US nicotine delivery product market
  81. Impact of nations meeting the MPOWER targets between 2014 and 2016: an update
  82. The US SimSmoke tobacco control policy model of smokeless tobacco and cigarette use
  83. The need for a comprehensive framework
  84. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products